|
rs555607708
|
CHEK2
1100delC
|
Frameshift deletion in the CHEK2 checkpoint kinase that abolishes kinase acti...
|
Cancer Risk
|
|
Established
|
|
rs6983267
|
8q24
|
Intergenic enhancer variant near MYC oncogene — modestly increases colorectal...
|
Cancer Risk
|
|
Established
|
|
rs1801155
|
APC
I1307K
|
Missense variant in the APC tumor suppressor that creates a hypermutable poly...
|
Cancer Risk
|
|
Strong
|
|
rs1799793
|
ERCC2
D312N
|
Missense variant in the XPD helicase that reduces nucleotide excision repair ...
|
Cancer Risk
|
|
Strong
|
|
rs25487
|
XRCC1
R399Q
|
Base excision repair scaffold protein that coordinates repair of oxidative DN...
|
Cancer Risk
|
|
Strong
|
|
rs11571833
|
BRCA2
K3326X
|
Moderate-penetrance stop-gain variant truncating the last 93 amino acids of B...
|
Cancer Risk
|
|
Strong
|
|
rs1805794
|
NBN
E185Q
|
Component of the MRN complex essential for DNA double-strand break repair, te...
|
Cancer Risk
|
|
Strong
|
|
rs2279744
|
MDM2
SNP309 T>G
|
Regulatory variant in the MDM2 promoter that increases Sp1 transcription fact...
|
Cancer Risk
|
|
Strong
|
|
rs1800734
|
MLH1
-93G>A
|
Promoter variant in the MLH1 DNA mismatch repair gene that reduces transcript...
|
Cancer Risk
|
|
Strong
|
|
rs16941
|
BRCA1
E1038G
|
Common missense variant in BRCA1 with debated association to modest breast ca...
|
Cancer Risk
|
|
Moderate
|
|
rs1799950
|
BRCA1
Q356R
|
Common missense variant near the BRCA1 RING finger domain; associated with mo...
|
Cancer Risk
|
|
Moderate
|
|
rs1867277
|
FOXE1
c.-283G>A
|
Functional 5' UTR variant in the FOXE1 thyroid transcription factor that incr...
|
Cancer Risk
|
|
Strong
|
|
rs17879961
|
CHEK2
I157T
|
Missense variant in the CHEK2 FHA domain that impairs phosphoprotein binding ...
|
Cancer Risk
|
|
Strong
|
|
rs2228000
|
XPC
Ala499Val
|
Missense variant in the DNA damage recognition gene XPC that moderately reduc...
|
Cancer Risk
|
|
Moderate
|